Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
Type 2 diabetes has reached epidemic proportions worldwide. The resulting increase in chronic and costly diabetes related complications has potentially catastrophic implications for healthcare systems, and economics and societies as a whole. One of the key pathological factors leading to type 2 diab...
Main Author: | Ummu Kulthum, Jamaludin |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://umpir.ump.edu.my/id/eprint/7733/1/UMMU_KULTHUM_JAMALUDIN.PDF |
Similar Items
-
Angiotensin II receptor blocker valsartan enhances glucose-induced insulin secretion
by: Ayob, Azizi, et al.
Published: (2006) -
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013) -
Feasibility Of An Intensive Control Insulin-Nutrition Glucose Model ‘Icing’ With Malaysian Critically-Ill Patient
by: Normy Norfiza, A. Razak, et al.
Published: (2016) -
Kesan in vitro rilmenidine ke atas rembesan insulin
by: Hashim, Rosnani, et al.
Published: (2003) -
The influence of genetic polymorphisms of CYP3A on the pharmacokinetic variation and clinical outcomes of tacrolimus in a cohort of patients / Mohd Rahimi Muda
by: Muda, Mohd Rahimi
Published: (2014)